Login to Your Account


CEOs of Newly Public Biotechs Balance Work and ... More Work

By Jennifer Boggs
Managing Editor

Thursday, April 18, 2013

The initial public offering (IPO) window may be creaking open for biotech – thanks in part to the new emerging growth company designation included in last year's JOBS Act – but running a publicly listed small biotech requires as much dedication as ever.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription